Enhancing Access to Addiction Treatment Act of 2018

Bill: 115-s-2711
Sponsor: full_name: Sen. Hassan, Margaret Wood [D-NH]
Introduced: 2018-04-19
Policy area: Crime and Law Enforcement
Subjects: Drug trafficking and controlled substances

Education programs funding

Health personnel

Health programs administration and funding

Licensing and registrations

Medical education

Teaching, teachers, curricula
Latest action: action_date: 2018-04-19
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2018-04-19
action_desc: Introduced in Senate
text: <p><b>Enhancing Access to Addiction Treatment Act of 2018</b></p> <p>This bill amends the Controlled Substances Act to expand the types of training that satisfy the training requirement to be a qualifying physician who may administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.</p> <p>Specifically, a physician who recently graduated from medical school (either allopathic or osteopathic) and successfully completed a comprehensive curriculum or residency that included training on treating and managing opiate-dependent patients satisfies the training requirement to be a qualifying physician. </p> <p>The Department of Health and Human Services must establish a grant program to support the development of such curricula by medical schools and teaching hospitals. </p>

tv_txt: II 115th CONGRESS 2d Session S. 2711 IN THE SENATE OF THE UNITED STATES April 19, 2018 Ms. Hassan (for herself and Mr. Portman ) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To amend section 303 of the Controlled Substances Act to facilitate waivers of the separate registration requirement for physicians dispensing narcotic drugs to individuals for maintenance treatment or detoxification treatment.

1. Short title This Act may be cited as the Enhancing Access to Addiction Treatment Act of 2018 . 2. Waivers for maintenance or detoxification treatment (a) Waiver Section 303(g)(2)(G)(ii) of the Controlled Substances Act ( 21 U.S.C. 823(g)(2)(G)(ii) ) is amended by adding at the end the following: (VIII) The physician graduated from an accredited school of allopathic medicine or osteopathic medicine in the United States during the 5-year period ending on the date on which the physician submits to the Secretary a written notification under subparagraph (B) and successfully completed a comprehensive allopathic or osteopathic medicine curriculum or accredited medical residency that— (aa) included not less than 24 hours of training on treating and managing opiate-dependent patients; and (bb) included, at a minimum— (AA) the training described in items (aa) through (gg) of subclause (IV); and (BB) training with respect to any other best practice the Secretary determines should be included in the curriculum, which may include training on pain management, including assessment and appropriate use of opioid and non-opioid alternatives. . (b) Grants (1) In general The Secretary of Health and Human Services shall establish a grant program under which the Secretary may make grants to accredited schools of allopathic medicine or osteopathic medicine and teaching hospitals located in the United States to support the development of curricula that meet the requirements under subclause (VIII) of section 303(g)(2)(G)(ii) of the Controlled Substances Act, as added by subsection (a). (2) Authorization of appropriations There are authorized to be appropriated for grants under paragraph (1), $4,000,000 for each of fiscal years 2019 through 2023. (c) Technical amendment Section 102(24) of the Controlled Substances Act ( 21 U.S.C. 802(24) ) is amended by striking Health, Education, and Welfare and inserting Health and Human Services .